Posttransplant complications in the setting of acute‐on‐chronic liver failure and considerations regarding immunosuppression
M. Valerie Lin, Fredric D. Gordon – 19 May 2022
M. Valerie Lin, Fredric D. Gordon – 19 May 2022
Rachel H. Westbrook, Elaine L. Burrell, Rajiv Jalan – 19 May 2022
Nadim Mahmud, K. Rajender Reddy – 19 May 2022
Laurens A. Kleef, Robert J. Knegt – 19 May 2022
Le Zhang, Shaoying Yang, Yongfu Yu, Suli Wang, Yuetian Yu, Yi Jin, Aimin Zhao, Yimin Mao, Liangjing Lu – 19 May 2022 – The appropriate prophylaxis for hepatitis B virus reactivation (HBVr) during gestation for immunocompromised pregnant women has yet to be determined. The prophylactic efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B surface antigen (HBsAg)–positive patients and the HBVr risk in hepatitis B core antibody (HBcAb)–positive patients during gestation were investigated.
Christian A. Hudert, Jake P. Mann – 19 May 2022
Rachel H. Westbrook, Elaine L. Burrell, Rajiv Jalan – 19 May 2022
Kinjal Patel, Puneeta Tandon, Ruben Hernaez – 19 May 2022
Joining AASLD means becoming a part of the premier organization committed to preventing and curing liver disease.
Read the latest article abstracts, practice guidelines, and more from HEPATOLOGY, Liver Transplantation, Clinical Liver Disease and Hepatology Communications.